Actively Recruiting
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
Led by Peking University First Hospital · Updated on 2024-11-07
200
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 68Ga-C1 in PET/CT imaging in clear cell renal cell carcinoma patients. It will also learn about the safety, tolerability and radiation dosimetry of 68Ga-C1. Researchers will compare the diagnostic value of 68Ga-C1 PET/CT and 18F-FDG PET/CT in Chinese patients with indeterminate renal masses or confirmed clear cell renal cell carcinoma.
CONDITIONS
Official Title
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed written informed consent
- Age 18 years or older
- Patients with confirmed or suspected clear cell renal cell carcinoma
- Expected survival of at least 6 months
You will not qualify if you...
- Renal mass known to be metastasis from another primary tumor
- Other malignancies requiring treatment
- Received chemotherapy, radiotherapy, or immunotherapy within 4 weeks
- Renal insufficiency with glomerular filtration rate (GFR) 60 mL/min/1.73 m² or less
- Pregnant or lactating women, or planning pregnancy within 6 months
- Uncontrolled psychiatric disorders
- Vulnerable populations (e.g., detention) or serious non-malignant diseases such as infectious, autoimmune, or metabolic diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
Research Team
K
Kan Gong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here